KRT87P

Across TCGA pan-cancer cohorts, KRT87P mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated KRT87P data layer compared with 23 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KRT87P mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated KRT87P expression acts as an unfavorable survival marker, although some lineages such as HNSC and UCEC show a favorable association.

HNSC and UCEC are the cancer types where KRT87P mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	IV	0.912	0.524	.034	2	view →
UCEC	OS	Median	All	0.977	0.855	.045	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

KRT87P–HNSC (OS)

Open the HNSC breakdown →